Leeward Pharmaceutical Private Limited
About Leeward Pharmaceutical Private Limited
Data last updated:
Leeward Pharmaceutical Private Limited is a private limited company based in Pune, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 18 November 2022.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U24290PN2022PTC216197.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Mayur Subhash Khedkar and Renuka Bhaskar Golhar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Pune, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹12.66 Lakh, a decline of 1% compared to the previous year. For the same year it recorded a net loss of ₹24,208 (net margin -1.9%) and EBITDA of -₹24,208 (EBITDA margin -1.9%).
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Leeward Pharmaceutical Private Limited's registered office is in Pune, Maharashtra.
- Registered AddressFl No B – 203 Gat No 167 206 Kalpak Homes Nandoshi Road, Khadakwasla, Pune, Maharashtra, India – 411024
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Leeward Pharmaceutical is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Leeward Pharmaceutical Private Limited, buy the company report.
Financials of Leeward Pharmaceutical Private Limited
FY 2025 filings availableLeeward Pharmaceutical Private Limited reported revenue of ₹12.66 Lakh (down 1% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 1% in the latest year. EBITDA fell 482% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | -₹24,208 | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | -₹24,208 | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | -1.9% | ||
| Net Profit Margin | -1.9% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Leeward Pharmaceutical Private Limited, buy the company report.
Board of directors of Leeward Pharmaceutical Private Limited
Leeward Pharmaceutical has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mayur Subhash Khedkar | Director | 18 Nov 2022 | 3 Years 11 Months | Current |
| Renuka Bhaskar Golhar | Director | 25 Apr 2023 | 3 Years 6 Months | Current |
Peer comparison
Leeward Pharmaceutical Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (retail trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Peovas Resource Solutions Private Limited | ₹12.67 Lakh (FY 2025) | -45.0% | Gurgaon, Haryana, India | |||
| Bakins Food Products Private Limited | ₹12.67 Lakh (FY 2025) | -66.0% | Jalna, Maharashtra, India | |||
| Cofarma Pharmaceuticals Private Limited | ₹12.67 Lakh (FY 2024) | -43.0% | Thalassery, Kerala, India | |||
| Aria Collective Private Limited | ₹12.67 Lakh (FY 2025) | 476.0% | Bangalore, Karnataka, India | |||
| Stakrr Lab Sciences Private Limited | ₹12.66 Lakh (FY 2024) | -56.0% | New Delhi, Delhi, India | |||
| Leeward Pharmaceutical Private Limitedthis company | ₹12.66 Lakh (FY 2025) | -₹24,208 | -1.9% | -1.0% | Pune, Maharashtra, India | |
| Al-Hayy Private Limited | ₹12.66 Lakh (FY 2025) | 7.0% | Barpeta, Assam, India | |||
| Shivkhori Realcon Limited | ₹12.66 Lakh (FY 2025) | 3.0% | Kolkata, West Bengal, India | |||
| Psyctes Pharmaceuticals Private Limited | ₹12.65 Lakh (FY 2025) | 59.0% | Jhunjhunu, Rajasthan, India | |||
| Whiteganga Medicos Private Limited | ₹12.65 Lakh (FY 2023) | -13.0% | Lucknow, Uttar Pradesh, India | |||
| Harshit Iron and Steel Private Limited | ₹12.65 Lakh (FY 2025) | 33.0% | Jamshedpur, Jharkhand, India |
To see the full peer comparison of Leeward Pharmaceutical Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Leeward Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Leeward Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Leeward Pharmaceutical Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Leeward Pharmaceutical Private Limited has 4 board changes on record since 2022: 2 appointments and 2 cessations. The latest: Renuka Bhaskar Golhar ceased to be Additional Director on 03 Dec 2023.
Frequently asked questions
Leeward Pharmaceutical is an active private limited company based in Pune, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 18 November 2022 (4+ years old) and is registered under CIN U24290PN2022PTC216197.
Leeward Pharmaceutical has 2 current directors:
- Mayur Subhash Khedkar - Director
- Renuka Bhaskar Golhar - Director
The latest financial statements of Leeward Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.
The CIN (Corporate Identification Number) of Leeward Pharmaceutical is U24290PN2022PTC216197. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Leeward Pharmaceutical was incorporated on 18 November 2022, making it 4+ years old. It is registered with the Registrar of Companies, Pune.
The peers of Leeward Pharmaceutical by revenue are Peovas Resource Solutions Private Limited, Bakins Food Products Private Limited, Cofarma Pharmaceuticals Private Limited, Aria Collective Private Limited, Stakrr Lab Sciences Private Limited and 5 more, all in the same principal business activity (retail trading).
Renuka Bhaskar Golhar ceased to be Additional Director on 03 Dec 2023. Ravi Narayan Atole ceased to be Director on 25 Apr 2023. Renuka Bhaskar Golhar was appointed as Director on 25 Apr 2023. Leeward Pharmaceutical has 4 board changes on record in total.
The registered office of Leeward Pharmaceutical is at Fl No B – 203 Gat No 167 206 Kalpak Homes Nandoshi Road, Khadakwasla, Pune, Maharashtra, India – 411024.
Leeward Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Leeward Pharmaceutical is compliant as of 21 July 2026. The company is actively filing with the Registrar of Companies.
Leeward Pharmaceutical can be reached at its registered office: Fl No B – 203 Gat No 167 206 Kalpak Homes Nandoshi Road, Khadakwasla, Pune, Maharashtra, India – 411024.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
